States Sue Bristol-Myers Alleging Firm Took Illegal Actions To Block Taxol Competitors
GM Prizes Awarded To Gleevec Pioneers Druker, Lydon, And To Peto, Sulston, Waterston
Clinical Trial System Inefficient, UPCI Director Tells Senate
Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading
NCCS Changes Web Domain; NCCN Plans Clinical Trials Network
Funding Opportunities.
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
- Scaling excellence: How City of Hope is transforming cancer care delivery
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research